Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (181-190 of 467) with videos related to

Pageof 47
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancerPaul Roepman, Hugo M Horlings, Oscar Krijgsman, et al.
Bone Marrow Transplantation|November 10, 2009
Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patientsY C Linn, C Y Phang, T J Lim, et al.
The Lancet. Oncology|November 3, 2009
Tumour tissue: who is in control?Martine Corrette Ploem, Valesca P Retèl, Sabine C Linn, et al.
Biotechnology and Bioengineering|February 8, 2018
Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension culturesJasmine M Corbin, Muchena J Kailemia, C Linn Cadieux, et al.
NPJ Breast Cancer|May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expressionLeonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Breast (Edinburgh, Scotland)|September 3, 2016
Low risk of recurrence in elderly patients treated with breast conserving therapy in a single instituteFemke van der Leij, Erik van Werkhoven, Sophie Bosma, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Experimental Dermatology|August 4, 2018
Nail abnormalities identified in an ageing study of 30 inbred mouse strainsSarah C Linn, Allison M Mustonen, Kathleen A Silva, et al.
Bone Marrow Transplantation|October 12, 2011
The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignanciesY-C Linn, M Niam, S Chu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2016
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)D B Y Fontein, A Charehbili, J W R Nortier, et al.
Pageof 47

Showing results (181-190 of 467) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Microarray-based determination of estrogen receptor, progesterone receptor, and HER2 receptor status in breast cancerPaul Roepman, Hugo M Horlings, Oscar Krijgsman, et al.
Bone Marrow Transplantation|November 10, 2009
Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patientsY C Linn, C Y Phang, T J Lim, et al.
The Lancet. Oncology|November 3, 2009
Tumour tissue: who is in control?Martine Corrette Ploem, Valesca P Retèl, Sabine C Linn, et al.
Biotechnology and Bioengineering|February 8, 2018
Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension culturesJasmine M Corbin, Muchena J Kailemia, C Linn Cadieux, et al.
NPJ Breast Cancer|May 13, 2023
Immune landscape of breast tumors with low and intermediate estrogen receptor expressionLeonie Voorwerk, Joyce Sanders, Milou S Keusters, et al.
Breast (Edinburgh, Scotland)|September 3, 2016
Low risk of recurrence in elderly patients treated with breast conserving therapy in a single instituteFemke van der Leij, Erik van Werkhoven, Sophie Bosma, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Experimental Dermatology|August 4, 2018
Nail abnormalities identified in an ageing study of 30 inbred mouse strainsSarah C Linn, Allison M Mustonen, Kathleen A Silva, et al.
Bone Marrow Transplantation|October 12, 2011
The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignanciesY-C Linn, M Niam, S Chu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2016
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)D B Y Fontein, A Charehbili, J W R Nortier, et al.
Pageof 47